BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  Arvinas to Report Second Quarter 2026 Financial Results on August 4, 2026

  July 28, 2026

   · 

  1 min read
• Press Releases

  Cullinan Therapeutics Announces Positive End-of-Phase 1 Meeting with FDA for CLN-049 and Advances Program to a Potentially Registrational Phase 2 Study in AML

  July 28, 2026

   · 

  8 min read
• Press Releases

  Atea Pharmaceuticals Meets Both Its Primary and Secondary Endpoints in the Phase 3 C-BEYOND North America Trial Evaluating Bemnifosbuvir/Ruzasvir for Hepatitis C Virus

  July 28, 2026

   · 

  12 min read
• Press Releases

  Syndax to Announce Second Quarter 2026 Financial Results and Host Conference Call and Webcast on August 4, 2026

  July 28, 2026

   · 

  1 min read
• Press Releases

  Repligen Reports Second Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance

  July 28, 2026

   · 

  22 min read
• Press Releases

  Antag Therapeutics Announces Dosing of First Patient in Phase 2a Trial of First-in-Class GIPR Antagonist AT7687

  July 28, 2026

   · 

  4 min read
• Press Releases

  NeurAxis to Host Second Quarter 2026 Results and Business Update Call on Tuesday, August 11, 2026

  July 28, 2026

   · 

  1 min read
• Press Releases

  Altimmune Announces Positive Topline Results from RECLAIM Phase 2 Trial of Pemvidutide in Alcohol Use Disorder

  July 28, 2026

   · 

  11 min read
• Press Releases

  908 Devices to Report Second Quarter 2026 Financial Results on August 11, 2026

  July 28, 2026

   · 

  1 min read
• Press Releases

  IQVIA Reports Second-Quarter 2026 Results

  July 28, 2026

   · 

  19 min read